Why integrated clinical AI, not disjointed solutions, will define the future of revenue cycle
Every revenue cycle leader is living with the same tension: knowing where the revenue cycle needs to go, but not being able to get there fast enough.
A 2026 SmarterDx survey, in partnership with The Health Management Academy (THMA), uncovered that just 18% of healthcare RCM leaders described their mid-cycle as more proactive than reactive — yet 62% said they expected to shift it significantly upstream within three years.
Despite recognizing the need for a proactive approach, getting there doesn’t feel within reach for many leaders.And the clock is ticking. Payers have automated their offense faster than legacy mid-cycle infrastructure was ever built to absorb. For every quarter a system stays reactive, that gap widens. And with it, monumental costs grow.
A single, targeted solution alone can make positive strides to help health systems recover the revenue they’ve earned. But the gap doesn’t close with one disjointed tool at a time. It closes with a connected clinical intelligence platform that understands the full patient story and applies that intelligence across every revenue cycle workflow, from authorization to appeals.
SmarterDx + The Health Management Academy survey (2026). [THMA] findings come from a survey of 81 revenue cycle leaders across U.S. health systems, supplemented by five in-depth C-suite interviews. Conducted by The Health Management Academy in partnership with SmarterDx.
Deloitte Insights Momentum Isn’t a Metric (Aug 2026) [Deloitte]
SmarterDx platform data. [SDx] findings reflect SmarterDx proprietary data and platform results.
Walk through what clinical AI surfaces in your own data.
Request a demo